washington  reuters    democratic presidential candidate hillary clinton called on pharmaceutical company mylan nv to voluntarily drop the price of its severe allergy treatment drug epipen  which has increased in price by more than  percent in the past decade   that s outrageous   and it s just the latest troubling example of a company taking advantage of its consumers   clinton said in a statement   it s wrong when drug companies put profits ahead of patients  raising prices without justifying the value behind them   clinton frequently said during the primary that she would fight pharmaceutical companies   part of an attempt to counter criticism that she was too closely tied to the insurance industry  she has released a proposal that she says will lower drug costs for consumers  mylan spokeswoman nina devlin did not respond to inquiries about clinton s criticism of the company  mylan acquired the product in   and the price increased from   in  to its current cost of    shares of mylan closed down more than  percent at    on the nasdaq   the price of epipen is outrageous   said robert weissman  president of consumer watchdog group public citizen   mylan is endangering lives and ripping off the country   weissman said epipen s u s  price should be rolled back sharply  noting the product is available for as little as   in canada  many other drugmakers also routinely raise prices of their prescription drugs by  percent or more each year  and u s  legislation is needed to prevent such  price spikes   he added  the white house took a more cautious tone in criticizing rising drug costs  refusing to comment on the decisions of an individual company    i will observe  however  that pharmaceutical companies that often try to portray themselves as the inventors of life saving medication often do real damage to their reputation by being greedy and jacking up prices in a way that victimizes   white house spokesman josh earnest said at a news briefing      clinton joins a bipartisan group of lawmakers who are calling for investigations into the price increase of epipens  which are preloaded injections of epinephrine  adrenaline  that people use if they are having a dangerous allergic reaction that untreated could result in death   republican senator chuck grassley  chairman of the senate judiciary committee  wrote mylan earlier in the week to ask for an explanation of the price change  senator amy klobuchar  the top democrat on the committee s antitrust subcommittee  called for an investigation by the federal trade commission  on wednesday  republican senator susan collins and democratic senator claire mccaskill requested that mylan provide a briefing for the senate to explain the price change  grassley and klobuchar  along with democratic senators patrick leahy and richard blumenthal and republican senator ron johnson  on wednesday said they had written to the food and drug administration to ask about its approval process for alternatives to the epipen   given the importance of this topic  it is imperative to understand the fda s role with respect to epipens and its approval of generic equivalents that could help to increase competition and lower prices if introduced   the senators said in a statement     we have reached out to every member of congress who has sent us a letter  and we look forward to meeting with them and responding to their questions as soon as possible   devlin said   in january  clinton admonished valeant pharmaceuticals international inc  which raised the price of a heart drug  in the wake of a clinton campaign blog post targeting valeant  the company s stock fell  in march  she released a campaign ad vowing to target the company specifically   clinton also criticized turing pharmaceuticals in the fall of  when public ire rose after it decided to raise the price of an antiviral medication commonly used by aids patients and pregnant women from    a tablet to   each   after a single post by clinton on the social media website twitter critical of turing  the company s stock price tumbled   at that time  clinton released a comprehensive drug price plan that she says would reduce costs  her proposal includes capping monthly out of pocket costs  expanding generic drug access and allowing americans to buy pharmaceuticals abroad   republican presidential candidate donald trump has said little about lowering drug prices  he has proposed increasing the amount of negotiations permitted by medicare in order to lower prices for those using the program  